ホーム › 潰瘍性大腸炎 › テキサス › San Antonio
San Antonio、TXにおける潰瘍性大腸炎の臨床試験
San Antonioとその周辺地域（約30マイル以内）の拠点で、潰瘍性大腸炎に関する16件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
被験者募集中第3相
- Southern Star Research Institute ( Site 0299), San Antonio
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
被験者募集中第2相
- Southern Star Research Institute /ID# 280822, San Antonio
Confirmatory Clinical Study in Active Ulcerative Colitis
被験者募集中第2相
- Southern Star Research Institute, San Antonio
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
被験者募集中第2相
- Gastroenterology Research of San Antonio, San Antonio
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
被験者募集中第1/2相健康なボランティア歓迎
- Xencor Investigative Site, San Antonio
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
被験者募集中第2相
- Site 002, San Antonio
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
被験者募集中第3相
- Southern Star Research Institute, LLC, San Antonio
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
被験者募集中第3相
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
被験者募集中第2相
- Southern Star Research Institute, San Antonio
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
被験者募集中第2相
- Southern Star Research Institute, San Antonio
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
被験者募集中第2相
- Southern Star Research Institute, San Antonio
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
被験者募集中第4相
- Gastroenterology Research of San Antonio, LLC, San Antonio
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
被験者募集中第3相
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
被験者募集中第3相
- Southern Star Research Institute, LLC, San Antonio
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
被験者募集中第3相
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
被験者募集中観察研究
- Brooke Army Medical center, San Antonio
- Brooke Army Medical center, San Antonio
他の都市における潰瘍性大腸炎の試験
- New York City, NY23件の研究
- Orlando, FL22件の研究
- Miami, FL21件の研究
- Houston, TX17件の研究
- Tacoma, WA15件の研究
- Chicago, IL15件の研究
- San Diego, CA15件の研究
- Tyler, TX14件の研究
- Colorado Springs, CO14件の研究
- Los Angeles, CA13件の研究
- St. Louis, MO13件の研究
- Washington, DC12件の研究
San Antonioにおける他の研究
- 非小細胞肺癌59件の研究
- 大腸癌46件の研究
- 乳がん46件の研究
- 転移性癌44件の研究
- がん（全種類）41件の研究
- 肥満症40件の研究
- 2型糖尿病37件の研究
- 過体重34件の研究
- 卵巣がん31件の研究
- 膵臓がん31件の研究
- 前立腺がん28件の研究
- 子宮内膜がん27件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。